Clinical Trial Update: Study of FK463 for the Treatment of Invasive Aspergillosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for FK463 in the treatment of invasive aspergillosis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Aspergillosis

Drugs mentioned

• FK463 (FK463)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Aspergillosis | Phase 2 | Status: COMPLETED